As New Jersey’s only NCI-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health, provides patients access to the most advanced treatment options including complex surgical procedures, sophisticated radiation therapy techniques, innovative clinical trials, immunotherapy, and precision medicine.
|
|
|
The 62nd Annual ASH Meeting: Rutgers Cancer Institute Experts Present Expansive Data |
|
|
|
The American Society of Hematology (ASH), is the world’s largest professional society with a focus on the causes and treatment of blood disorders. Experts from Rutgers Cancer Institute of New Jersey and RWJBarnabas Health will be presenting a variety of key hematology data at the 62nd ASH Annual Meeting, which is being held virtually from December 5-8. This includes more than twenty scheduled presentations, including 10 oral presentations examining several types of blood cancers including leukemia, lymphoma, and myeloma. Read more for highlights and a full list of Rutgers Cancer Institute presentations.
|
|
Exploring Autophagy as a Therapeutic Strategy in Non-Small Cell Lung Cancer |
|
|
|
Lung cancer is the leading cause of death in both men and women with non-small cell lung cancer accounting for more than 85 percent of these cases. Patients with co-mutations of KRAS and LKB1, which are two of the most frequent mutations detected in non-small cell lung cancer, are often resistant to standard treatment and develop aggressive tumors. ‘Jessie’ Yanxiang Guo, PhD, researcher at Rutgers Cancer Institute of New Jersey, has received a $1.7 million award from the National Institutes of Health to investigate the role of a cellular survival mechanism known as autophagy in the formation of tumors driven by these mutations with the hope of exploring potential treatment for this type of lung cancer. Learn more
|
|
Rutgers Cancer Institute Radiation Oncology Leader Named President-Elect of the RNSA Board |
|
|
|
The Radiological Society of North America (RNSA) is an international society of radiologists, medical physicists and other medical professionals across the world, with the mission of promoting excellence in patient care and health care delivery through education, research and technologic innovation. This year, Bruce G. Haffty, MD, associate vice chancellor for cancer programs and chair, radiation oncology at Rutgers Cancer Institute of New Jersey has been named president-elect of the society. Learn more
|
|
Studying the Role of Enhancers in T-cell Acute Lymphoblastic Leukemia Development |
|
|
|
Researchers from Rutgers Cancer Institute of New Jersey identified a novel enhancer that interacts with a tumor suppressor gene and examined its involvement in the development of normal T-cells in T-cell acute lymphoblastic leukemia (T-ALL). Daniel Herranz, PharmD, PhD, researcher at Rutgers Cancer Institute and assistant professor of pharmacology at Rutgers University is the senior author of the work published in Blood Cancer Discovery, a journal of the American Association for Cancer Research. Learn more
|
|
Caregiving for Cancer Patients during COVID-19 |
|
|
|
Caregivers supporting a loved one with cancer are faced with new challenges during the COVID-19 pandemic including protecting their own safety while assuring their loved one with cancer is also safe from the virus and being taken care of through their cancer journey. Deborah Leif MSW, LCSW, Stephanie Quiroga MSW, LCSW and Sandra Bruno MSW, LSW, licensed clinical social workers at Rutgers Cancer Institute of New Jersey offer advice for caregivers during this challenging time as they face the difficult task of supporting their loved one and caring for themselves. Learn more
|
|
|
|
|
|
|
